SCHEMBL23735872

SCHEMBL23735872

CCN1CCN(C(C)C)CC1CO

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
GBA1 P04062 1/20 0.32
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24204582 1.00 GAA (0.34) GAAL3MBTL1GBA1HTT
SCHEMBL23373698 0.86 GAA (0.39) GAAL3MBTL1
SCHEMBL26170213 0.84 GBA1 (0.31) GBA1
SCHEMBL20866118 0.81
SCHEMBL24448878 0.80 L3MBTL1 (0.35) L3MBTL1HTT
SCHEMBL26639390 0.79 HRH3 (0.31)
SCHEMBL26639368 0.79
SCHEMBL25089492 0.79
SCHEMBL24338113 0.77
SCHEMBL26635491 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022012622-A1 DEGRADATION OF (EGFR) BY CONJUGATION OF EGFR INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE BEIGENE, LTD. (KY) 2022-01-20 WO disclosed
EP-3558955-B1 BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER AMGEN INC (US) 2021-08-11 EP disclosed